INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE);Universite Paris Descartes;Assistance Publique-Hopitaux de Paris (APHP)
发明人:
Hafid AIT-OUFELLA
申请号:
US15759850
公开号:
US20180251552A1
申请日:
2016.10.11
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The present invention relates to a method for treating MI or AMI in a subject in need thereof comprising a step of administering to said subject a therapeutically effective amount of an agent capable of depleting CD8 T cells. More particularly, this present invention relates to a method for treating acute myocardial infarction by reducing the size of necrosis and limiting 10 the post ischemic left ventricular remodeling.